8.82Open0.30Pre Close24 Volume36 Open Interest150.00Strike Price8.41KTurnover445.26%IV0.37%PremiumAug 16, 2024Expiry Date2.45Intrinsic Value100Multiplier-1DDays to Expiry0.55Extrinsic Value100Contract SizeAmericanOptions Type-0.7055Delta0.0788Gamma45.40Leverage Ratio-47.3863Theta0.0000Rho-32.03Eff Leverage0.0034Vega
Repligen Stock Discussion
Gapping up
$Meta Platforms (META.US)$ +0.81% (The social media gianted in premarket trading after the launch of Threads, a direct competitor to Twitter. Meta CEO Mark Zuckerberg said on his Threads account early Thursday that 10 million people had signed up for the platform in seven hours after launching.)
$Sweetgreen (SG.US)$ +5.14% (Sweetgreen jumped more than 4% after Bank of America upgraded...
Gap Ups
1. $PLDT (PHI.US)$ - up 2.6%
2. $Avis Budget (CAR.US)$ - up 2.2%
3. $Bank Bradesco SA(prefer share ADS) (BBD.US)$ - up 0.8%
4. $Sanofi (SNY.US)$ - up 0.7%
5. $Grifols (GRFS.US)$ - up 0.4%
6. $Lumentum (LITE.US)$ - up 0.3%
Gap Downs
1. $Bilibili (BILI.US)$ - down 4.0%
2. $Olin (OLN.US)$ - ...
Gap Ups
1. $Teck Resources (TECK.US)$ - up 10.6%
2. $Apellis Pharmaceuticals (APLS.US)$ - up 9.5%
3. $Apache (APA.US)$ - up 5.8%
4. $Schlumberger (SLB.US)$ - up 5.0%
5. $TotalEnergies (TTE.US)$ - up 4.9%
6. $Shell (SHEL.US)$ - up 3.8%
7. $BP PLC (BP.US)$ - up 3.7%
8. $Transocean (RIG.US)$ ...
- Netflix - I always wanted to buy but never liked the price. Now with its 50-day MA set to pass its 200, I figure I might as well jinx it with my minimal TA knowledge.
- Crox - Declining ROIC, but still at 24% in its last quarter, even bringing HEYDUDE into the fold.
- Repligen - Picks and shovels play to the biotech industry, and I want to increase my exposure there.
$Netflix (NFLX.US)$ $Crocs (CROX.US)$ $Repligen (RGEN.US)$ $Disney (DIS.US)$
Can keep this one in watchlist for next week. Interesting price action. Price already up after earnings yet a flush down. Volume were high but still managed to close green above key lvl. A tell tale for hunting SL. A gd entry will be 257.50. SL will be -1% from there. (If price does drop to 257.50, see if it cut under first, enter after rebound lest it hit your -1%). As long price stay below that lvl, setup is void
$AstraZeneca (AZN.US)$ AstraZeneca (AZN) target raised by SVB Leerink from $71 to $73 at Outperform. Stock currently around $59
$Best Buy (BBY.US)$ Best Buy (BBY) target raised by Piper Sandler from form $146 to $150 at Overweight. Stock currently around $110
$Costco (COST.US)$ Costco (COST) target raised by Credit Suisse from $400 to $490 at Neutral. Stock currently around $460
$Repligen (RGEN.US)$ rgenRepligen (RGEN) target raised by Craig Hallum from $258 to $368 at Buy. Stock currently around $305
No comment yet